Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ian

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 28, 2012
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patientsArnab Chakravarti, Meihua Wang, H Ian Robins, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320Paul W Sperduto, Meihua Wang, H Ian Robins, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium studyMichael D Prados, W K Alfred Yung, Howard A Fine, et al.
Neuro-Oncology|March 15, 2006
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, Kathleen Lamborn, W K A Yung, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical studyCraig A Schulz, Minesh P Mehta, Benham Badie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant gliomaJohn G Kuhn, Susan M Chang, Patrick Y Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium StudyTimothy F Cloughesy, John Kuhn, H Ian Robins, et al.
American Journal of Clinical Oncology|May 22, 2012
ACR Appropriateness Criteria® follow-up and retreatment of brain metastasesSamir H Patel, Jared R Robbins, Elizabeth M Gore, et al.
Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with afliberceptJohn F de Groot, Yuji Piao, Hai Tran, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
International Journal of Radiation Oncology, Biology, Physics|November 28, 2012
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patientsArnab Chakravarti, Meihua Wang, H Ian Robins, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320Paul W Sperduto, Meihua Wang, H Ian Robins, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium studyMichael D Prados, W K Alfred Yung, Howard A Fine, et al.
Neuro-Oncology|March 15, 2006
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium studyMichael D Prados, Kathleen Lamborn, W K A Yung, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical studyCraig A Schulz, Minesh P Mehta, Benham Badie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant gliomaJohn G Kuhn, Susan M Chang, Patrick Y Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium StudyTimothy F Cloughesy, John Kuhn, H Ian Robins, et al.
American Journal of Clinical Oncology|May 22, 2012
ACR Appropriateness Criteria® follow-up and retreatment of brain metastasesSamir H Patel, Jared R Robbins, Elizabeth M Gore, et al.
Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with afliberceptJohn F de Groot, Yuji Piao, Hai Tran, et al.
Pageof 12